drugset / Trial / NCT04745637

Managed Access Programs for INC424, Ruxolitinib

NCT04745637

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to INC424, Ruxolitinib

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Ruxolitinib Small molecule